BANK1 |
Q8NDB2
|
B cell scaffold protein with ankyrin repeats 1
|
|
4.8E-12 |
0.653 |
0.538 |
RAB4A |
P20338
|
RAB4A, member RAS oncogene family
|
|
0.20 |
0.705 |
0.577 |
ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
TNFSF13B |
Q9Y275
|
TNF superfamily member 13b
|
|
0.98 |
0.460 |
0.731 |
ICOS |
Q9Y6W8
|
inducible T cell costimulator
|
|
3.1E-02 |
0.502 |
0.731 |
DOCK11 |
Q5JSL3
|
dedicator of cytokinesis 11
|
Enzyme modulator
|
1.2E-02 |
0.606 |
0.731 |
MIR326 |
|
microRNA 326
|
|
|
0.560 |
0.731 |
BLK |
P51451
|
BLK proto-oncogene, Src family tyrosine kinase
|
Kinase
|
8.3E-14 |
0.585 |
0.769 |
HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
SMN1 |
Q16637
|
survival of motor neuron 1, telomeric
|
Epigenetic regulator
|
1.6E-02 |
0.454 |
0.769 |
SMN2 |
Q16637
|
survival of motor neuron 2, centromeric
|
|
0.10 |
0.459 |
0.769 |
STAT4 |
Q14765
|
signal transducer and activator of transcription 4
|
Nucleic acid binding
|
0.77 |
0.471 |
0.769 |
AIM2 |
O14862
|
absent in melanoma 2
|
|
2.2E-09 |
0.521 |
0.769 |
IL21 |
Q9HBE4
|
interleukin 21
|
|
0.63 |
0.441 |
0.769 |
FCRL3 |
Q96P31
|
Fc receptor like 3
|
Cell adhesion
|
6.0E-21 |
0.612 |
0.769 |
GZMB |
P10144
|
granzyme B
|
Enzyme
|
3.7E-14 |
0.453 |
0.808 |
PTPRC |
P08575
|
protein tyrosine phosphatase receptor type C
|
Enzyme
|
1.00 |
0.435 |
0.808 |
TNFSF4 |
P23510
|
TNF superfamily member 4
|
Signaling
|
4.9E-02 |
0.540 |
0.808 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
BTG3 |
Q14201
|
BTG anti-proliferation factor 3
|
|
0.92 |
0.528 |
0.808 |
IFIH1 |
Q9BYX4
|
interferon induced with helicase C domain 1
|
|
7.0E-44 |
0.471 |
0.808 |
IL17F |
Q96PD4
|
interleukin 17F
|
|
3.9E-02 |
0.480 |
0.808 |
CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
DNASE1 |
P24855
|
deoxyribonuclease 1
|
|
7.0E-21 |
0.505 |
0.846 |
EPHB2 |
P29323
|
EPH receptor B2
|
Kinase
|
1.00 |
0.374 |
0.846 |